Evaluatieagenda

Intensive Care

  • Early initiation of extracorporeal life support in refractory ventricular fibrillation

    843001707

  • Dose lndividualizAtion of Beta-lactam AntiBiotics in ICU patients: to TDM or not to TDM and the effects on patient outcome'

    848017008

    Dose lndividualizAtion of Beta-lactam AntiBiotics in ICU patients: to TDM or not to TDM and the effects on patient outcome

  • Posaconazole prophylaxis to prevent influenza-associated aspergillosis in critically ill patients: a randomized trial.

    848018001

  • Reduced Anticoagulation Targets in Extracorporeal life support (RATE)'

    848018014

  • Efficacy of haloperidol to decrease the burden of delirium in adult critically ill patients: a prospective randomised multi-center double-blind placebo-controlled clinical trial

    848041001

  • The effects of Automated Closed-loop versus convenTIonal VEntilation on duration and quality of ventilation (‘ACTIVE’) - a randomized clinical trial in intensive care unit patients

    852002031

  • The impact of high versus standard enteral protein provision on functional recovery following Intensive Care admission: a randomized controlled, multicenter, parallel group trial in mechanically ventilated, critically ill patients

    852101074

Evaluatieagenda

ZE&GG - Zorgevaluatie & Gepast Gebruik
Actueel Aan de slag Wat we doen Over ZE&GG
Zoeken
HUB Dashboard Nieuws Bibliotheek Werkruimten Apps
Back to menu
Samen voor de bewezen beste zorg voor patiënten
Volg ZE&GG: op Linkedin

Actueel

  • Nieuws
  • Bijeenkomsten & webinars

Aan de slag

  • Kennisagenda
  • Evaluatieagenda
  • Implementatieagenda

Wat we doen

  • Agenderen
  • Evalueren
  • Implementeren & monitoren
  • Systeeminbedding

Over ZE&GG

  • MSZ partijen
  • Team
  • Wat is zorgevaluatie en wat is gepast gebruik?
  • Gerelateerde programma's
  • Veelgestelde vragen
  • ZE&GG Nieuwsbrieven
  • Contact
Cookies Digitale toegankelijkheid Disclaimer Privacy Responsible disclosure

© 2023/2024 ZE&GG